Systemic drug-related intertriginous and flexural exanthema (SDRIFE) induced by the Comirnaty Pfizer-BioNTech COVID-19 vaccine: A report of 2 cases
Sign Up to like & getrecommendations! Published in 2021 at "Dermatology online journal"
DOI: 10.1016/j.jdcr.2021.10.016
Abstract: A 72-year-old man with a history of metastatic melanoma presented with a two-day history of erythematous and edematous plaques, with scattered bullae on the neck, chest, axillae, and inguinal and gluteal folds, which began five… read more here.
Keywords: systemic drug; related intertriginous; drug; drug related ... See more keywords
Symmetric drug–related intertriginous and flexural exanthema–like eruption related to coronavirus disease 2019 vaccine
Sign Up to like & getrecommendations! Published in 2022 at "Contact Dermatitis"
DOI: 10.1111/cod.14092
Abstract: A 53-year-old man presented with an erythematous papular skin eruption. Ten days prior to the appearance of the lesions, he had received the second dose of the coronavirus disease 2019 (COVID19) vaccine (ChAdOx1 nCoV-19 [AstraZeneca]).… read more here.
Keywords: coronavirus disease; intertriginous flexural; eruption; flexural exanthema ... See more keywords
Symmetric drug-related intertriginous and flexural exanthema
Sign Up to like & getrecommendations! Published in 2020 at "Cutis"
DOI: 10.12788/cutis.0140
Abstract: To the Editor: Symmetric drug-related intertriginous and flexural exanthema (SDRIFE) is a curious disorder that has undergone many clinical transformations since first being described by Andersen et al1 in 1984 using the term baboon syndrome.… read more here.
Keywords: intertriginous flexural; symmetric drug; drug; drug related ... See more keywords